In diseases marked by cardiac developmental anomalies, such as DCM, VSD, and LVNC, the loss of CASZ1 expression or genetic mutations can contribute to aberrant cardiac morphogenesis. This evidence concerns the gene CASZ1 and ventricular septal defect.